Benefits and therapeutic applications of the use of Cannabidiol: A literature review of future perspectives

Authors

DOI:

https://doi.org/10.33448/rsd-v12i13.44203

Keywords:

Cannabis; Cannabidiol; Mechanism of action; Therapeutic effects; Legislation.

Abstract

Introduction: The use of Cannabis in a medicinal form has been reported since ancient times, as has its use in a narcotic form. As it spread throughout the world, its psychotropic effects gained strength and interest, highlighting components such as delta-9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD). Methodology: the latter is of great scientific interest due to its beneficial effects on diseases such as arthritis, Alzheimer's, Parkinson's, anxiety, schizophrenia and depression. Results and discussion: CBD stands out for its complex therapeutic action, showing promise due to its effectiveness and lower incidence of side effects compared to other medications, but highlights the need for regulation by the National Health Surveillance Agency (Anvisa). Currently, patients who need CBD often turn to the Judiciary due to the State's refusal to provide the medicine. The diversity of CBD's biological targets opens up possibilities for its application for different purposes, encouraging research into new pharmaceutical formulations, pre-clinical trials and clinical trials in humans. Final considerations: The work aims to promote a bibliographical survey on studies and treatments with CBD, exploring its effectiveness and future prospects. However, the association of Cannabis as a recreational drug creates a stigma regarding its medicinal use, it is crucial to understand that, like other medicines, Cannabis, especially CBD, has significant therapeutic potential and should be considered as a valid option in the treatment of various diseases and clinical conditions.

Author Biographies

Jean Colacite, Centro Universitário Descomplica Uniamérica

master in clinical analysis.

Layse Fernanda Antonio de Souza, Centro Universitário Descomplica Uniamérica

Master in Public Health in Border Region.

References

Almeida, V., Seabra, G. Reis-de-Oliveira, G. et al. (2022). Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes. Eur Arch Psychiatry Clin Neurosci. 272(7), 1311 23. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwi3raqC1umCAxUTqZUCHc91AKYQFnoECAkQAQ&url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F35622101%2F&usg=AOvVaw0zzn2gJTmJXqHfSzD7amKc&opi=89978449

Alves, P., Amaral, C., Teixeira, N et al. (2020). Cannabis sativa: Muito mais além do Δ 9 - tetrahidrocanabinol. Pharmacological Research. 21(4), 95. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjHl_-R1-mCAxUmr5UCHYy0AzQQFnoECAgQAQ&url=https%3A%2F%2Fperiodicoscientificos.ufmt.br%2Fojs%2Findex.php%2Fbiodiversidade%2Farticle%2Fview%2F14798%2F11719&usg=AOvVaw2thRq2W-L9p7iLu4J_H_j2&opi=89978449

American Psychiatric Association et al. (2014) DSM-5: Manual diagnóstico e estatístico de transtornos mentais. Artmed Editora, v.5 315-317. https://books.google.com.br/books?hl=pt-BR&lr=&id=QL4rDAAAQBAJ&oi=fnd&pg=PT13&dq=AMERICAN+PSYCHIATRIC+ASSOCIATION +et+al.+(2014)++DSM-5:+Manual+diagn%C3%B3stico+e+estat%C3%ADstico+de+transtornos+mentais.+Artmed+Editora,&ots=nSZCuGwcCT&sig =ewIUoz5V_I8pW2oeYX4uoBc7yQ4

Anderson C. L., Evans V. F., Demarse T. B., Febo M., John-son C. R., & Carney P. R. (2017). Cannabidiol for the Treatment of Drug-Resistant Epilepsy in Children: Current State of Research. J Pediatr Neurol. 15(4), https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjOi_S3ouqCAxUzK7kGHb65B24QFnoECA4QAQ&url=https%3A%2F%2Fwww.semanticscholar.org%2Fpaper%2FCannabidiol-for-the-Treatment-of-Drug-Resistant-in-Anderson-Evans%2Fb97d03846f0a6560a4cd23d78e5bef2866928819&usg=AOvVaw1orhVuAhvyBmC09tTOUCXW&opi=89978449

Blessing, E. M., Steenkamp, M. M., Manzanares, J. et al. (2015). Canabidiol como um tratamento potencial para transtornos de ansiedade. The American Society for Experimental NeuroTherapeutics, 12, 825-836. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjP2dypo-qCAxWqK7kGHR9 qAf4QFnoECAkQAQ&url=https%3A%2F%2Fojs.brazilianjournals.com.br%2Fojs%2Findex.php%2FBJHR%2Farticle%2Fview%2F59522&usg=AOvVaw0nI95uFeaJc8iF1PjAroFK&opi=89978449

Bonini S. A., Premoli M., Tambaro S., Kumar A., Maccarinelli G., Memo M. et al. (2018). Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. J Ethnopharmacol. 5(227):300-315. https://pubmed.ncbi.nlm.nih.gov/30205181/ https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiz9aeBpOqCAxVUIbkGHbpgBzUQFnoECAgQAQ&url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F30205181%2F&usg=AOvVaw0lUgzoRfFTi-vjCDi7uMEF&opi=89978449

Brasil. (2022). Anvisa aprova mais três produtos de Cannabis para uso medicinal. ANVISA. Edição: 86, Seção: 1, Página: 87. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwi_mfvppOqCAxV2KrkGHV0jDeAQFnoECA8QAQ&url=https%3A%2F%2Fwww.gov.br%2Fanvisa%2Fpt-br%2Fassuntos%2Fnoticias-anvisa%2F2022%2Fanvisa-aprova-mais-tres-produtos-de-cannabis-para-uso-medicinal&usg=AOvVaw3GRHkK2zFytOjCnssgU9ZH&opi=89978449

Brasil. (2019). Dispõe sobre os procedimentos para a concessão da Autorização Sanitária para afabricação e a importação, bem como estabelece requisitos para a comercialização, prescrição, a dispensação, o monitoramento e a fiscalização de produtos de Cannabis para fins medicinais, e dá outras providências. ANVISA. V.1. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjKyOi3peqCAxX5q5UCHd7EDKUQFnoECBkQAQ&url=https%3A%2F%2Fwww.gov.br%2Fanvisa%2Fpt-br%2Farquivos-noticias-anvisa%2F895json-file-1&usg=AOvVaw0E1PpJWu9odIDw1vVy_Mhc&opi=89978449

Brasil. (2020). Define os critérios e os procedimentos para a importação de Produto derivado de Cannabis, por pessoa física, para uso próprio, mediante prescrição de profissional legalmente habilitado, para tratamento de saúde. ANVISA. n4. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwj43e-UpuqCAxXLL7kGHQplChMQF noECDAQAQ&url=https%3A%2F%2Fwww.gov.br%2Fanvisa%2Fpt-br%2Fassuntos%2Fnoticias-anvisa%2F2021%2Fanvisa-otimiza-processo-de-avaliacao-da-importacao-de-produtos-derivados-de-cannabis-por-pessoa-fisica&usg=AOvVaw2Yy28-zv7RSPugBIyNSl98&opi=89978449

Brown, A. J. (2007). Novel cannabinoid receptors. British Journal of Pharmacology. 152, 567. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjtwZSmp-qCAxWcG7kGHSq3BYwQFno ECAoQAQ&url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F17906678%2F&usg=AOvVaw1b9pdqrzxA112-BlQ0yYaU&opi=89978449

Crippa, J. A. S., Zuardi, A. W., & Hallak, J. E. C. (2010). Uso terapêutico dos canabinoides em psiquiatria. Brazilian Journal of Psychiatry, v. 32. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjZvPfOp-qCAxV8LbkGHQXYAAUQF noECAgQAQ&url=https%3A%2F%2Fwww.scielo.br%2Fj%2Frbp%2Fa%2FSLJjHfPvnpyKPQX79wbnztp%2F&usg=AOvVaw05xDMNB_APkOR5fL37jFOc&opi=89978449

Dall’stella, P. B., Docema, M. F. L., Maldaun, M. V. C et al. (2019). Case report: Clinical Outcome and Image Response of Two Patients with Secondary High-Grade Glioma Treated with Chemoradiation, PCV, and Cannabidiol. Frontiers in Oncology. v8. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiVn_z5p-qCAxWuK7kGHVKaAaIQF noECAkQAQ&url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F30713832%2F&usg=AOvVaw1KK_yGWn9978Yr2nY4dSkT&opi=89978449

De freitas, D. et al. (2022). El papel de los cannabinoides en los trastornos del neurodesarrollo de niños y adolescentes. Revista de Neurología, 75(7) p. 189-197. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiOm-mXqOqCAxXQObkGHSYxBu QQFnoECA4QAQ&url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10280762%2F&usg=AOvVaw24fVNdI1GYVS1MKNlF6KxZ&opi=89978449

Devinsky, O., Cilio, M. R., Cross, H et al. (2016). Canabidiol: Farmacologia e potencial papel terapêutico na epilepsia e outros distúrbios neuropsiquiátricos. HHS Public Access, 55(6), 791-802. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjv49vKqOqCAxUwDrkGHXtoBeIQFnoECAgQAQ&url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F24854329%2F&usg=AOvVaw31Z8EVnbykIKvXebl-Yo5x&opi=89978449

Fonseca B. M., Soares A., Teixeira N., & Silva G. C. (2019). Canábis e Canabinoides para Fins Medicinais. Revista Portuguesa de Farmacoterapia. 11(1), 21-31. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjXrPf8qOqCAxXdGbkGHRs5A9oQFnoECAgQAQ&url=http%3A%2F%2Frevista.farmacoterapia.pt%2Findex.php%2Frpf%2Farticle%2Fview%2F211&usg=AOvVaw0TJ3PkFDhUd8a9YS1Oe2ng&opi=89978449

Gabardo E., & Cabral R. M. (2020). Autorização para uso de medicamentos com princípios ativos proscritos no Brasil. Rev. Investig. Const. 7(2):473-515. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiThaDlqeqCAxWsKLkGHbeqAs8QFnoECAoQAQ&url=https%3A%2F%2Fwww.scielo.br%2Fj%2Frinc%2Fa%2FBWJhLvc9FtCB94BmZPbfxNQ%2Fabstract%2F%3Flang%3Dpt&usg=AOvVaw06tQrr20s6YVI7Z3tofwhl&opi=89978449

Gadia C. A., Tuchman R., & Rotta N. T. (2004). Autismo e doenças invasivas de desenvolvimento. J Pediatr (Rio J). 80S83-S94. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjl6dC1quqCAxVaLrkGHUpMBMcQFnoECAgQAQ&url=https%3A%2F%2Fwww.scielo.br%2Fj%2Fjped%2Fa%2FmzVV9hvRwDfDM7qVZVJ6ZDD%2F&usg=AOvVaw1RQNJrRX0gf8jJ-3qdF7Tc&opi=89978449

Gevins, Ilan A. B., A, Coleman M., ElSohly M. A., & de Wit, H. (2005). Neurophysiologicaland subjective profile of marijuana with varying concentrationsof cannabinoids. Behav Pharmacol. 16:487-96. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwi6k52kq-qCAxUzp5UCHYmm BYQQFnoECAQQAQ&url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F16148455%2F&usg=AOvVaw36qgQqyXtshPXXKr2WwUgr&opi=89978449

Karhson D. S., Hardan A. Y., & Parker K. J. (2016). Endocannabinoid signaling in social functioning: An RDoC perspective. Transl Psychiatry. 31: 463–469. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwipxZnfq-qCAxVEl5UCHQwMBXQQFnoECAw QAQ&url=https%3A%2F%2Fouci.dntb.gov.ua%2Fen%2Fworks%2F40OdLJp7%2F&usg=AOvVaw0F71veiI0zi-2feHVIoiMr&opi=89978449

Li, X., Diviant, J. P., Stith, S. S et al. (2022). The effects of consuming Cannabis Flower for treatment of fatigue. Medical Cannabis and Cannabinoids, 5, 76-84, 2022. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwivi7LSteqCAx XMLLkGHT3UByUQFnoECBsQAQ&url=https%3A%2F%2Fperiodicoscientificos.ufmt.br%2Fojs%2Findex.php%2Fbiodiversidade%2Farticle%2Fview%2F14798%2F11719&usg=AOvVaw2thRq2W-L9p7iLu4J_H_j2&opi=89978449

Massi, A., Demayo, M. M., Glozier, N., & Guastella, A. J. (2017). An Over-view of Autism Spectrum Disorder, Heterogeneity and Treatment Options. Neurosci Bull. 33(2):183-193. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiIssr-teqCAxVqJ7kGHYF_Amk QFnoECAoQAQ&url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F28213805%2F&usg=AOvVaw1GyN_ntSRuXK-nXz5NAONg&opi=89978449

Matos, R. L. A. et al. (2017) O uso do canabidiol no tratamento da epilepsia. Revista Virtual de Química, Niterói, 9(2), 786-814. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwi__LOmtuqCAxUhALkGHSl6BX0QFnoECAkQAQ&url=http%3A%2F%2Frvq.sbq.org.br%2Faudiencia_pdf.asp%3Faid2%3D744%26nomeArquivo%3Dv9n2a24.pdf&usg=AOvVaw0RBe530AdHpkNOsfJuOGvU&opi=89978449

Mechoulam, R., & Hanus, L. (2022). Cannabidiol: an overview of some chemical pharmacological aspects. Part I: chemical aspects. Chemistry Physics Lipids, 121, 35. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwi7tLGct-qCAxXIILkGHX95BBUQF noECAkQAQ&url=https%3A%2F%2Fwww.researchgate.net%2Fpublication%2F6080805_Cannabidiol_An_overview_of_some_chemical_and_pharmacological_aspects_Part_I_Chemical_aspects&usg=AOvVaw1eb_TtQa8Esvqe7_kHglBj&opi=89978449

Melo, L. A., & Santos, A. O. (2016). O uso do Canabidiol no Brasil e o posicionamento do órgão regulador. Cadernos Ibero-Americanos de Direito Sanitário, Brasília, DF, 5(2), 43-55. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiGibPPt-qCAxU5OrkGHcwWAc4QFnoECAoQAQ&url=https%3A%2F%2Fwww.cadernos.prodisa.fiocruz.br%2Findex.php%2Fcadernos%2Farticle%2Fview%2F231&usg=AOvVaw0cOobHhG0rUwhvcJC7-bbQ&opi=89978449

Oliveira, K. L. B., & Lima, T. P. S. (2016). Cannabis Sativa: Potencial Terapêutico. Monografia (apresentada como requisito parcial à obtenção do grau de Bacharel em Biomedicina) – Faculdade São Lucas, Porto Velho-RO. p.30. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwi9_Jbyt-qCAxXrqZUCHSjXBs4QF noECAwQAQ&url=https%3A%2F%2Fdoceru.com%2Fdoc%2Fnes05c05&usg=AOvVaw0odkwq524D7MFigpt-_-lc&opi=89978449

Ortiz, Y. T., Mcmahon, L. R., & Wilkerson, J. L. (2022) Cannabis Medicinal e Distúrbios do Sistema Nervoso Central. Review Article. 13. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwijs-C1uOqCAxXaqJUCHfArAAcQFnoECAoQAQ&url=https %3A%2F%2Fwww.frontiersin.org%2Farticles%2F10.3389%2Ffphar.2022.881810&usg=AOvVaw1GchOYQpDxnARhOY1C-2zd&opi= 89978449

Pagano, C., Navarra, G., Copolla, L et al. (2022). Canabinóides: Uso Terapêutico na Prática Clínica. International Journal of Molecular Sciences, v. 23. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjp6L_0oeqCAxVFKLkGHXW6D64QFnoECAkQAQ&url=https%3A%2F%2Fwww.scielo.br%2Fj%2Frbp%2Fa%2FSLJjHfPvnpyKPQX79wbnztp%2F&usg=AOvVaw05xDMNB_APkOR5fL37jFOc&opi=89978449

Pedrazzi, J. F. C. et al. (2014) Perfil antipsicótico do canabidiol. Faculdade de Medicina USP, 47(2), 112–119. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjczrLQoeqCAxWvLrkGHY0FDfoQFnoECAoQAQ&url=https%3A%2F%2Fwww.revistas.usp.br%2Frmrp%2Farticle%2Fview%2F84556&usg=AOvVaw3jygd9UdBEH1LdUhImLUC9&opi=89978449

Pinto, W. S., & Cipriano, V. T. F. (2015) Uso terapêutico de canabinoides: perspectivas e implicações no contexto forense. Revista Acta de Ciências e Saúde, 1(4), 13-30. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwi45dz4oOqCAxUUE7kGHYJFC3gQF noECAoQAQ&url=https%3A%2F%2Finterfaces.unileao.edu.br%2Findex.php%2Frevista-interfaces%2Farticle%2Fdownload%2F741%2Fpdf&usg= AOvVaw 1UVj-dTZdaEinWo_CUB1yi&opi=89978449

Quintero J., Navas M, Fernández A., & Ortiz T. (2009). Advances in attention deficit hyperactivity disorder.What does neuroimaging provide us with? Actas Esp Psiquiatr, 37(6):352-8. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiylID2n-qCAxWvLrkGHY0FDfoQFno ECA4QAQ &url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F20066587%2F&usg=AOvVaw3u0Q0cyY7epXTLm9vohJJr&opi=89978449

Saito, V. M., Wotjak, C. T., & Moreira, F. A. (2010). Exploração farmacológica do sistema endocanabinoide: novas perspectivas para o tratamento de transtornos de ansiedade e depressão? Revista Brasileira de Psiquiatria, 32(1) https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwij3Ja5n-qCAxU7O7kGHcQlBAIQFnoECAkQAQ& url=https%3A%2F%2Fwww.scielo.br%2Fj%2Frbp%2Fa%2FdPP9G5tCc8NNkbBj6cbjcwk&usg =AOvVaw3UjQudD8zlg5tfbnFjjG_P&opi=89978449

Schilling S., Melzer R, & McCabe P. F. (2019). Cannabis sativa. Current Biology. 30(1): R1–R9. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjE0cXznuqCAxXZILkGHZT6Ac8QFnoECAgQAQ&url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F31910378%2F&usg=AOvVaw0Fq4j6ffGPpdPo-WUScoHG&opi=89978449

Schubart, C. D., Sommer, I. E., Fusar-Poli, P., Witte, L., Kahn, R. S., & Boks, M. P. (2014) Cannabidiol as a potential treatment for psychosis. European Neuropsychopharmacology. 24, 51. [PubMed] https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwi7uZSynuqCAxXvFLkGHTZhC2EQFnoECAkQAQ&url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F24309088%2F&usg=AOvVaw2h8bN2DQ7CC5TCdw3SWh5b&opi=89978449

Souza, A. A. F., Silva, A. F. M., Silva, T. F. & Oliveira, C. R. (2019). Cannabis sativa: Uso de fitocanabinóides para o tratamento da dor crônica. Brazilian Journal of Natural Sciences. 2(1): 20. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiwr4bRneqCAxU0IbkGHRUvCJYQFnoECAoQAQ&url=https%3A%2F%2Fbjns.com.br%2Findex.php%2FBJNS%2Farticle%2Fview%2F30&usg=AOvVaw3WmKdmtJ1iiXLlH4Yry8jW&opi=89978449

Souza, T. M., et al. (2010). Revisão integrativa: o que é e como fazer. Journal Einstein. 2010, 8(1 Pt 1):102-6. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjq1sGDnuqCAxWjH7kGHXYJBFIQFnoECAgQAQ&url=https%3A%2F%2Fjournal.einstein.br%2Fpt-br%2Farticle%2Frevisao-integrativa-o-que-e-e-como-fazer%2F&usg=AOvVaw2bdiCLTJAIqPgMg5QAqraa&opi=89978449

Published

02/12/2023

How to Cite

SPOHR, F. C.; COLACITE, J.; SOUZA, L. F. A. de . Benefits and therapeutic applications of the use of Cannabidiol: A literature review of future perspectives. Research, Society and Development, [S. l.], v. 12, n. 13, p. e86121344203, 2023. DOI: 10.33448/rsd-v12i13.44203. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/44203. Acesso em: 13 may. 2024.

Issue

Section

Health Sciences